At a glance
ClinicalIndex Comparison RecordN/ACompleted· 536 enrolled
Drug / intervention
Stannous fluorideother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Real-World Evidence Study Evaluating Oral Health Related Quality Of Life With Use Of A Stannous Fluoride Anti-Sensitivity Toothpaste For Dentin Hypersensitivity Management
In Brief
A clinical study evaluating Stannous fluoride for Dentin Sensitivity. Completed, enrolled 536 participants across 1 site.
Detailed Summary
This study will evaluate the impact of long-term use of a desensitizing toothpaste containing 0.454 percent (%) stannous fluoride (SnF2) on oral health related quality of life (OHrQoL) in a population of self-reported dentin hypersensitivity (DH) sufferers. Data generated will provide real world information on the DH experience and DH management with a daily use anti-sensitivity treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentin Sensitivity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedSep 2023
Enrollment StartSep 2023
Primary CompletionApr 2024
TodayJul 2026
First PostedSep 21, 2023
Enrollment StartSep 21, 2023
Primary CompletionApr 25, 2024
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 2.8 years ago
Interventions
Stannous fluorideother
Anti-sensitivity toothpaste containing 0.454% Stannous Fluoride